Stock listing
0I3Q Stock Price, News, Filings & Events — Corcept Therapeutics Incorporated
Selected listing: 0I3Q · LSE · USD · GB
This page tracks Corcept Therapeutics Incorporated's 0I3Q:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0I3Q:LSE. 0I3Q:LSE is the stock-level entry point for investors researching Corcept Therapeutics Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Corcept Therapeutics Incorporated (CORT) is a publicly traded company based in the United States, with a market capitalization of approximately $10.24 billion. The company focuses on developing and commercializing innovative therapies for the treatment of various medical conditions. Corcept is committed to advancing its research and providing effective solutions for patients.
- Ticker
- 0I3Q:LSE
- Asset type
- Stock
- Market cap
- $12.31B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSE
- Currency
- USD
Corcept Therapeutics Incorporated 0I3Q:LSE stock context
This page tracks Corcept Therapeutics Incorporated's 0I3Q:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0I3Q:LSE. 0I3Q:LSE is the stock-level entry point for investors researching Corcept Therapeutics Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Corcept Therapeutics Incorporated (CORT) is a publicly traded company based in the United States, with a market capitalization of approximately $10.24 billion. The company focuses on developing and commercializing innovative therapies for the treatment of various medical conditions. Corcept is committed to advancing its research and providing effective solutions for patients.
Latest news from Corcept Therapeutics Incorporated
CORRECTION FROM SOURCE: Corton Capital Inc. Announces August 2026 Distributions for the Exchange Traded Fund
August 25, 2026
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome
June 17, 2026
Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercort...
June 6, 2026
Corcept Presents New Data at ASCO 2026: Lifyorli™ Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cance...
May 29, 2026
Corcept to Resubmit its New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome
May 27, 2026
Corcept Therapeutics Incorporated earnings calls
Corcept Therapeutics Incorporated (CORT) Q2 2026 Earnings Call
July 29, 2026 · Replay with transcript and chapters
Corcept Therapeutics Incorporated (CORT) Q1 2026 Earnings Call
April 30, 2026 · Replay with transcript and chapters
Corcept Therapeutics Incorporated (CORT) Q4 2025 Earnings Call
February 24, 2026 · Replay with transcript and chapters
Corcept Therapeutics Incorporated (CORT) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Corcept Therapeutics Incorporated (CORT) Q2 2025 Earnings Call
July 31, 2025 · Replay with transcript and chapters
Corcept Therapeutics Incorporated (CORT) Q1 2025 Earnings Call
May 5, 2025 · Replay with transcript and chapters
Research Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated investor report
Review AI stock analysis and investor report context for 0I3Q:LSE.
Corcept Therapeutics Incorporated company profile
View the public company page for Corcept Therapeutics Incorporated on 6ix.
Corcept Therapeutics Incorporated news
Read company news and market updates connected to Corcept Therapeutics Incorporated.
Corcept Therapeutics Incorporated investor events
Find investor webinars, events, and replay context for Corcept Therapeutics Incorporated.
Alternate listings
CORT:NASDAQ
US · USD
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
HTD:GETTEX
DE · EUR
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
529882:LSX
DE · EUR
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
529882:LS
DE · EUR
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
CORT:BOATS
US · USD
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
HTD:TRADEGATE
DE · EUR
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
1CORT:MIL
IT · EUR
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
HTD:FWB
DE · EUR
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
HTD:BX
CH · CHF
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
HTD:DUS
DE · EUR
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
HTD:HAM
DE · EUR
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.
HTD:MUN
DE · EUR
Alternate listing for Corcept Therapeutics Incorporated; the primary context on this page is 0I3Q:LSE.